Frentzas Sophia - Department of Medical Oncology, Monash Health

基本信息

浏览量：13

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 94 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

A gut microbial signature for combination immune checkpoint blockade across cancer types

Ashray Gunjur,Yan Shao, Timothy Rozday,Oliver Klein,Andre Mu,Bastiaan W. Haak,Ben Markman,Damien Kee,Matteo S. Carlino,Craig Underhill,Sophia Frentzas,Michael Michael,Bo Gao,Jodie Palmer,Jonathan Cebon,Andreas Behren,David J. Adams,Trevor D. Lawley

Nature Medicineno. 3 (2024): 797-809

引用0浏览0WOSNATURE引用

Abstract PO1-04-01: Phase 1 dose escalation study of ARX788, a next-generation anti-HER2 antibody drug conjugate, in heavily pretreated breast cancer patients

Sophia Frentzas, Haesong Park, George Budd,Vinod Ganju,Catherine Shannon,Sara Hurvitz,Katharine Cuff,Peter Lau,Richard Eek,Joyce O'Shaughnessy,Fran Boyle,Sandra Aung, Colin Hessel,Janice Lu

Cancer Researchno. 9_Supplement (2024): PO1-04

引用0浏览0引用

CD74 is Associated with Inflamed Tumor Immune Microenvironment and Predicts Responsiveness to PD-1/CTLA-4 Bispecific Antibody in Patients with Solid Tumors

Jianghua Wang,Xiaoting Li,Guanxi Xiao,Jayesh Desai,Sophia Frentzas,Zhongmin Maxwell Wang,Yu Xia,Baiyong Li

Cancer immunology, immunotherapy/Cancer immunology and immunotherapyno. 2 (2024)

引用0浏览0WOS引用

#88 Lenvatinib plus pembrolizumab versus chemotherapy as first-line therapy for advanced or recurrent endometrial cancer: primary results of the phase 3 ENGOT-en9/LEAP-001 study

Christian Marth,Richard G Moore,Mariusz Bidzinski,Sandro Pignata,Ali Ayhan,M Jesús Rubio,Mario Beiner,Marcia Hall,Christof Vulsteke,Elena Ioana Braicu,Kenzo Sonoda,Xiaohua Wu,Sophia Frentzas, André Mattar,Jodi McKenzie, Lili Yao,Vivek Khemka,Lucy Gilbert,Vicky Makker

Late Breaking Abstracts (2024)

引用0浏览0引用

Phase 1a Dose Escalation Study of Ivonescimab (AK112/SMT112), an Anti-Pd-1/vegf-a Bispecific Antibody, in Patients with Advanced Solid Tumors

Sophia Frentzas,Anna Rachelle Austria Mislang,Charlotte Lemech,Adnan Nagrial,Craig Underhill,Wenjing Wang,Zhongmin Maxwell Wang,Baiyong Li,Yu Xia,Jermaine I. G. Coward

Journal for immunotherapy of cancerno. 4 (2024): e008037-e008037

引用0浏览0引用

Cln-619 (Anti-Mica/b Antibody) Alone and in Combination with Pembrolizumab (P) for Advanced Solid Tumors: Updated Results of a Ph1 Study

Ignacio Melero Bermejo,Judy S. Wang,Martin Gutierrez,Erika Hamilton, Alexander I. Spira,Drew W. Rasco,John D. Powderly,Michael Millward,Sophia Frentzas, Rafał Stec,Manish Sharma, Mark Shackleton,Ana Arance, Julia Giner Joaquin,Iwona Ługowska,Tracy Liu, Todd Shearer, Divya Gupta, Jeffrey A. Jones,Víctor Moreno

Journal of clinical oncologyno. 16_suppl (2024): 2588-2588

引用0浏览0引用

Equitable Access to Genomic Molecular Testing for Australian Cancer Patients: Insights from the Victorian Precision Oncology Summit

Genevieve Dall, Karen Harris, Nonie Chan, Stephen J Luen,Sophia Frentzas,Daphne Day,Michelle Barrett, Anna Kilgour,Mark Buzza

Current oncology (Toronto, Ont)no. 8 (2024): 4519-4530

引用0浏览0WOS引用

Updated Results of a Phase 1/2 Study of AU-007, a Monoclonal Antibody (mab) That Binds to IL-2 and Inhibits CD25 Binding, in Patients with Advanced Solid Tumors

Drew W. Rasco,Meredith McKean, Andrew Haydon, Andrew Weickhardt,Sophia Frentzas,Elizabeth Ahern,John D. Powderly,Timothy Wyant,Jenny Tang,Lori Richards, Aron Knickerbocker, Inbar Amit, Yishai Ofran, James R. Vasselli

Journal of clinical oncologyno. 16_suppl (2024): 2527-2527

引用0浏览0引用

Abstract PD18-09: ACE-Breast-03: Efficacy and Safety of ARX788 in Patients with HER2+ Metastatic Breast Cancer Previously Treated with T-DM1

Sara A. Hurvitz,Kevin Kalinsky,Vinod Ganju,Kashif Ali, Laila Agrawal,William J. Gradishar,George W. Sledge,Anu Thummala,Arlene Chan,Sophia Frentzas,Joohyuk Sohn, Kyong-Hwa Park,Keon Uk Park,Catherine Shannon,Joshua Z. Drago,Sara M. Tolaney,Hope Rugo,Michael F. Press, Alex Alika,Dianguo Xu,Janice Lu,Debu Tripathy

Cancer researchno. 5_Supplement (2023): PD18-09

引用0浏览0引用

Pamiparib in Combination with Tislelizumab in Patients with Advanced Solid Tumours: Results from the Dose-Expansion Stage of a Multicentre, Open-Label, Phase I Trial

Michael Friedlander,Linda Mileshkin,Janine Lombard,Sophia Frentzas,Bo Gao,Michelle Wilson,Tarek Meniawy,Sally Baron-Hay,Karen Briscoe,Nicole McCarthy,Christos Fountzilas,Andres Cervantes,Ruimin Ge,John Wu,Alexander Spira

British journal of cancer（2023）

引用0浏览0WOSNATURE引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn